227 related articles for article (PubMed ID: 29349912)
1. Meta-analysis generates and prioritizes hypotheses for translational microbiome research.
Duvallet C
Microb Biotechnol; 2018 Mar; 11(2):273-276. PubMed ID: 29349912
[No Abstract] [Full Text] [Related]
2. Neuromuscular disorders: from diagnosis to translational research, drug development and clinical trials.
Tasker RC; Darras BT
Curr Opin Pediatr; 2013 Dec; 25(6):674-5. PubMed ID: 24240286
[TBL] [Abstract][Full Text] [Related]
3. Evidence needs to be translated, whether or not it is complete.
Dacks PA; Bennett DA; Fillit HM
JAMA Neurol; 2014 Feb; 71(2):137-8. PubMed ID: 24297103
[No Abstract] [Full Text] [Related]
4. New insights into the microbiota of wild mice.
Kwon HK; Seong JK
Mamm Genome; 2021 Aug; 32(4):311-318. PubMed ID: 34241667
[TBL] [Abstract][Full Text] [Related]
5. Spatiotemporal molecular medicine: A new era of clinical and translational medicine.
Wang X; Fan J
Clin Transl Med; 2021 Jan; 11(1):e294. PubMed ID: 33463066
[No Abstract] [Full Text] [Related]
6. [Research progress of gut microbiota and microbiota-targeted therapy in critical ill patients].
Xu R; Tan C; Yin J; Pan S
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Nov; 30(11):1099-1102. PubMed ID: 30541654
[TBL] [Abstract][Full Text] [Related]
7. Examining the Role of Microbiota-Centered Interventions in Cancer Therapeutics: Applications for Urothelial Carcinoma.
Drobner JC; Lichtbroun BJ; Singer EA; Ghodoussipour S
Technol Cancer Res Treat; 2023; 22():15330338231164196. PubMed ID: 36938621
[TBL] [Abstract][Full Text] [Related]
8. Pros and cons: Is faecal microbiota transplantation a safe and efficient treatment option for gut dysbiosis?
Marrs T; Walter J
Allergy; 2021 Jul; 76(7):2312-2317. PubMed ID: 33483999
[TBL] [Abstract][Full Text] [Related]
9. [The Link Between Gut Microbiota and Cerebral Functions: An Update on the Pathogenesis and Treatment of Functional Gastrointestinal Disorders].
Kurokawa S
Brain Nerve; 2021 Aug; 73(8):857-862. PubMed ID: 34376591
[TBL] [Abstract][Full Text] [Related]
10. The potential of fecal microbiota transplantation in systemic sclerosis.
Hoffmann-Vold AM; Fretheim H; Didriksen H; Molberg Ø
Expert Rev Clin Immunol; 2020 Feb; 16(2):117-118. PubMed ID: 31858856
[No Abstract] [Full Text] [Related]
11. Editorial: Diagnosis and Treatment of Primary Aldosteronism: from Clinical Origin to Translational Research.
Wu WC; Wei Q; Wu VC
Front Endocrinol (Lausanne); 2021; 12():781105. PubMed ID: 34917034
[No Abstract] [Full Text] [Related]
12. Therapeutic implications of probiotics in microbiota dysbiosis: A special reference to the liver and oral cancers.
Singh D; Khan MA; Siddique HR
Life Sci; 2021 Nov; 285():120008. PubMed ID: 34606851
[TBL] [Abstract][Full Text] [Related]
13. [Research progress on the relationship between gut microbiota dysbiosis and osteoarthritis].
Jiang S; Shen B
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2023 Mar; 37(3):371-376. PubMed ID: 36940999
[TBL] [Abstract][Full Text] [Related]
14. Biobanking in radiotherapy trials - a challenge to the clinical research community.
Gilbert DC; Speirs V
Nat Rev Clin Oncol; 2021 Apr; 18(4):191-192. PubMed ID: 33597721
[No Abstract] [Full Text] [Related]
15. [The role of gut microbiota dysbiosis in the occurrence and development of inflammatory bowel disease and its prevention and control strategies].
Yang ZY; Li M
Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Sep; 56(9):1175-1181. PubMed ID: 36207877
[TBL] [Abstract][Full Text] [Related]
16. Role of Probiotics in Human Gut Microbiome-Associated Diseases.
Kim SK; Guevarra RB; Kim YT; Kwon J; Kim H; Cho JH; Kim HB; Lee JH
J Microbiol Biotechnol; 2019 Sep; 29(9):1335-1340. PubMed ID: 31434172
[TBL] [Abstract][Full Text] [Related]
17. Microbiota in Health and Disease-Potential Clinical Applications.
Laudes M; Geisler C; Rohmann N; Bouwman J; Pischon T; Schlicht K
Nutrients; 2021 Oct; 13(11):. PubMed ID: 34836121
[TBL] [Abstract][Full Text] [Related]
18. Gut Microbiota and Dysbiosis in Alzheimer's Disease: Implications for Pathogenesis and Treatment.
Liu S; Gao J; Zhu M; Liu K; Zhang HL
Mol Neurobiol; 2020 Dec; 57(12):5026-5043. PubMed ID: 32829453
[TBL] [Abstract][Full Text] [Related]
19. The clinical impact of gut microbiota in chronic kidney disease.
Kim SM; Song IH
Korean J Intern Med; 2020 Nov; 35(6):1305-1316. PubMed ID: 32872729
[TBL] [Abstract][Full Text] [Related]
20. Dysbiosis in the Development of Type I Diabetes and Associated Complications: From Mechanisms to Targeted Gut Microbes Manipulation Therapies.
Gradisteanu Pircalabioru G; Corcionivoschi N; Gundogdu O; Chifiriuc MC; Marutescu LG; Ispas B; Savu O
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33803255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
